1-Benzyl-3-(5′-hydroxymethyl-2′-furyl)-indazole (YC-1) derivatives as novel inhibitors against sodium nitroprusside-induced apoptosis

Journal of Medicinal Chemistry

Volumn 45, Issue 23, 2002, Pages 4947-4949

  Lien, Jin Cherng ^a   Lee, Fang Yu ^b   Huang, Li Jiau ^a   Pan, Shiow Lin ^c   Guh, Jih Hwa ^c   Teng, Che Ming ^c   Kuo, Sheng Chu ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Yung Shin Pharmaceutical Industry Co Ltd   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; NITROPRUSSIDE SODIUM;

APOPTOSIS; ARTICLE; BLOOD VESSEL TONE; CELL GROWTH; DERIVATIZATION; INFLAMMATORY CELL; NONHUMAN; SEPTIC SHOCK; SMOOTH MUSCLE FIBER; THROMBOCYTE AGGREGATION INHIBITION; VASCULAR SMOOTH MUSCLE;

ADMINISTRATION, ORAL; ANIMALS; APOPTOSIS; CELLS, CULTURED; ENZYME ACTIVATORS; INDAZOLES; MICE; MUSCLE CELLS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE DONORS; NITROPRUSSIDE; RATS; SEPSIS;

EID: 0037038321     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm020070b     Document Type: Article

References (19)

1. Stone, R. Search for sepsis drugs goes on despite past failures. Science 1994, 264, 365-367.
2. Karima, R.; Matsumoto, S.; Higashi, H.; et al. The molecular pathogenesis of endotoxic shock and organ failure. Mol. Med. Today 1999, 5, 123-132.
3. Parrillo, J. E.; Parker, M. M.; Natanson, C.; et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 1990, 113, 227-242.
4. Ortolani, O., Conti, A., De Gaudio, A. R.; et al. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am. J. Respir. Crit. Care Med. 2000, 161, 1907-1911.
5. Kox, W. J.; Volk, T.; Kox, S. N.; et al. Immunomodulatory therapies in sepsis. Intensive Care Med. 2000, 26, S124-S128.
6. Boyle, W. A., III; Parvathaneni, L. S.; Bourlier, V.; et al. iNOS gene expression modulates microvascular responsiveness in endotoxin-challenged mice. Circ. Res. 2000, 87, E18-E24.
7. Glauser, M. P. Pathophysiologic basis of sepsis: Considerations for future strategies of intervention. Crit. Care Med. 2000, 28, S4-S8.
8. Nakatsu, K.; Diamond, J. Role of cGMP in relaxation of vascular and other smooth muscle. Can. J. Physiol. Pharmacol. 1989, 67, 251-262.
9. Guh, J. H.; Hwang, T. L.; Ko, F. N.; et al. Antiproliferative effect in human prostatic smooth muscle cells by nitric oxide donor. Mol. Pharmacol. 1998, 53, 467-474.
10. Ochoa, J. B.; Udekwu, A. O.; Billiar, T. R.; et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 1991, 214, 621-626.
11. Curran, R. D.; Billiar, T. R.; Stuehr, D. J.; et al. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J. Exp. Med. 1989, 170, 1769-1774.
12. Nakayama, D. K.; Geller, D. A.; Lowenstein, C. J.; et al. Cytokines and lipopolysaccharide induce nitric oxide synthase in cultured rat pulmonary artery smooth muscle. Am. J. Respir. Cell. Mol. Biol. 1992, 7, 471-476.
13. Rees, D. D. Role of nitric oxide in the vascular dysfuntion of septic shock. Biochem. Soc. Trans. 1995, 23, 1025-1029.
14. Lee, F. Y.; Lien, J. C.; Huang, L. J.; Huang, T. M.; Tsai, S. C.; Teng, C. M.; Wu, C. C.; Cheng, F. C.; Kuo, S. C. Synthesis of 1-Benzyl-3-(5′-hydroxymethyl-2′-furyl)indazole analogues as novel antiplatelet agents. J. Med. Chem. 2001, 44, 3746-3749.
15. Kuo, S. C.; Lee, F. Y.; Teng, C. M. 1-(Substituted benzyl)-3-(Substituted aryl) Condensed Pyrazole Derivatives and Processes of Making the Same. U.S. Patent 5574168, 1996.
16. Wu, C. C.; Ko, F. N.; Kuo, S. C.; et al. 27 Inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br. J. Pharmacol. 1995, 116, 1973-1978.
17. Wu, C. C.; Ko, F. N.; Teng, C. M. Inhibition of platelet adhesion to collagen by cGMP-elevating agents. Biochem. Biophys. Res. Commun. 1997, 231, 412-416.
18. Mulsch, A.; Bauersachs, J.; Schafer, A.; et al. Effect of 27, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br. J. Pharmacol. 1997, 120, 681-689.
19. Friebe, A.; Schultz, G.; Koesling, D. Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J. 1996, 15, 6863-6868.